AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $11.42
- 52-wk high
- $19.98
- High
- $11.56
- 52-wk low
- $9.58
- Low
- $11.25
- Prev close
- $11.43
- Mkt cap
- $2.88B
- P/E
- 49.8x
- Volume
- 2.63M
- Fwd P/E
- 35.7x
- Beta
- 1.15
- P/S
- 5.6x
- P/B
- 5.3x
- Profit margin
- +11.4%
- Op margin
- +5.3%
- ROE
- +12.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in $0.04 a share below what analysts expected.
Earnings per share
$0.09 expected
What the street expects next
EPS expected
$0.14 to $0.17
Revenue expected
8 analysts
Last 30 days
Split both ways
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $126.0M | $128.8M | $128.3M | $131.1M |
| Cost of what it sold | $20.3M | $19.7M | $22.4M | $25.2M |
| Gross profit | $105.7M | $109.1M | $105.9M | $105.9M |
| What it spent | ||||
| Research and development | $28.1M | $29.9M | $35.9M | $36.0M |
| Sales and admin | $19.8M | $19.9M | $17.7M | $63.0M |
| Other operating costs | $38.8M | $38.6M | $43.2M | — |
| Total operating expenses | $86.7M | $88.3M | $96.8M | $98.3M |
| What was left | ||||
| Operating profit | $19.0M | $20.8M | $9.1M | $7.6M |
| Profit before tax | $24.3M | $26.3M | $13.6M | $11.2M |
| Tax | $4.1M | $5.0M | $2.7M | $4.8M |
| Net profit | $20.2M | $21.3M | $10.9M | $6.4M |
| EBITDA | $27.0M | $49.5M | $20.6M | $16.5M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies
BullishSep 2Cellebrite DI Ltd (CLBT) Stock Drops 29% as Law Firm Investigates Potential Securities Violations After Q2 Miss and CEO Departure
BearishSep 2Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies
BullishSep 2Kaplan Fox Announces an Investigation of Cellebrite DI Ltd. (NASDAQ: CLBT) on Behalf of Investors
BearishSep 2A federal cybersecurity review covered 110 safeguards. Cellebrite’s unit earned accreditation.
BullishSep 1Cellebrite Federal Solutions, Inc. (CFSI) Achieves U.S. Department of War's Advanced Cybersecurity Standard, Reinforcing Commitment to Secure Federal Operations
BullishSep 1How Cellebrite’s New C-TEK Kit and Genesis Expansion Could Reframe Cellebrite DI (CLBT) Investors
Leans bullishAug 31Kaplan Fox is Investigating Potential Securities Law Violations Against Cellebrite DI Ltd. (NASDAQ: CLBT)
BearishAug 28
Macro
20 macro signals shaping CLBT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results